Sarepta Therapeutics, Inc. (SRPT)
USD 49.3
(-5.92%)
USD 49.3
(-5.92%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -439.19 Million USD | 43.44% |
| 2022 | -582.11 Million USD | -14.9% |
| 2021 | -306.08 Million USD | 22.14% |
| 2020 | -453.37 Million USD | -12.75% |
| 2019 | -652.66 Million USD | -36.95% |
| 2018 | -316.65 Million USD | -43.58% |
| 2017 | -34.75 Million USD | 10.5% |
| 2016 | -261.11 Million USD | -21.14% |
| 2015 | -214.78 Million USD | -68.07% |
| 2014 | -129.97 Million USD | -91.94% |
| 2013 | -88.41 Million USD | -207.05% |
| 2012 | -27.59 Million USD | 192.47% |
| 2011 | -34.62 Million USD | -765.22% |
| 2010 | -19.47 Million USD | -61.64% |
| 2009 | -14.12 Million USD | 47.09% |
| 2008 | -22.48 Million USD | 74.15% |
| 2007 | -25.15 Million USD | -16.69% |
| 2006 | -28.98 Million USD | -99.07% |
| 2005 | -14.67 Million USD | 32.98% |
| 2004 | -22.88 Million USD | -9.46% |
| 2003 | -17.38 Million USD | -8.32% |
| 2002 | -24 Million USD | -740.68% |
| 2001 | -14.84 Million USD | 76.36% |
| 2000 | -9.82 Million USD | -24.36% |
| 1999 | -8 Million USD | -168.7% |
| 1998 | -7.6 Million USD | 402.63% |
| 1997 | -3.4 Million USD | -100.0% |
| 1996 | -1.7 Million USD | 9.52% |
| 1995 | -2.1 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 64.45 Million USD | -4.15% |
| 2024 Q2 | 12.03 Million USD | -79.37% |
| 2023 Q2 | -101.36 Million USD | 5.92% |
| 2023 FY | - USD | 43.44% |
| 2023 Q4 | -28.46 Million USD | -327.99% |
| 2023 Q1 | -107.75 Million USD | -32.23% |
| 2023 Q3 | 12.48 Million USD | 112.31% |
| 2022 FY | - USD | -14.9% |
| 2022 Q4 | -81.49 Million USD | 27.4% |
| 2022 Q3 | -112.23 Million USD | 44.49% |
| 2022 Q1 | -77.63 Million USD | 18.88% |
| 2022 Q2 | -202.17 Million USD | -160.43% |
| 2021 FY | - USD | 22.14% |
| 2021 Q1 | -132.81 Million USD | 18.25% |
| 2021 Q2 | -159.48 Million USD | -20.08% |
| 2021 Q3 | -24.12 Million USD | 84.87% |
| 2021 Q4 | -95.69 Million USD | -296.6% |
| 2020 Q3 | -130.89 Million USD | -0.22% |
| 2020 Q2 | -130.61 Million USD | -24.04% |
| 2020 FY | - USD | -12.75% |
| 2020 Q1 | -105.3 Million USD | 49.47% |
| 2020 Q4 | -162.46 Million USD | -24.12% |
| 2019 Q4 | -208.39 Million USD | -88.93% |
| 2019 Q2 | -87.86 Million USD | -39.8% |
| 2019 Q3 | -110.3 Million USD | -25.53% |
| 2019 Q1 | -62.85 Million USD | 54.83% |
| 2019 FY | - USD | -36.95% |
| 2018 Q2 | -99.84 Million USD | -294.07% |
| 2018 FY | - USD | -43.58% |
| 2018 Q4 | -139.14 Million USD | -99.11% |
| 2018 Q3 | -69.88 Million USD | 30.01% |
| 2018 Q1 | -25.33 Million USD | -10.5% |
| 2017 Q4 | -22.93 Million USD | -479.09% |
| 2017 FY | - USD | 10.5% |
| 2017 Q1 | -164.24 Million USD | -85.81% |
| 2017 Q2 | -57.66 Million USD | 64.89% |
| 2017 Q3 | 6.04 Million USD | 110.49% |
| 2016 Q3 | -56.53 Million USD | 8.96% |
| 2016 FY | - USD | -21.14% |
| 2016 Q1 | -58.3 Million USD | 9.54% |
| 2016 Q4 | -88.39 Million USD | -56.36% |
| 2016 Q2 | -62.1 Million USD | -6.51% |
| 2015 Q3 | -50.45 Million USD | -23.61% |
| 2015 FY | - USD | -68.07% |
| 2015 Q1 | -61.86 Million USD | -38.33% |
| 2015 Q2 | -40.81 Million USD | 34.02% |
| 2015 Q4 | -64.45 Million USD | -27.75% |
| 2014 FY | - USD | -91.94% |
| 2014 Q2 | -25.52 Million USD | -19.58% |
| 2014 Q1 | -21.34 Million USD | 62.44% |
| 2014 Q3 | -36.88 Million USD | -44.48% |
| 2014 Q4 | -44.72 Million USD | -21.26% |
| 2013 Q2 | -14.88 Million USD | -224.62% |
| 2013 Q1 | 11.94 Million USD | -71.47% |
| 2013 Q3 | -7.48 Million USD | 49.7% |
| 2013 Q4 | -56.83 Million USD | -659.19% |
| 2013 FY | - USD | -207.05% |
| 2012 Q3 | 35.81 Million USD | 291.68% |
| 2012 FY | - USD | 192.47% |
| 2012 Q2 | -18.68 Million USD | -524.13% |
| 2012 Q1 | 4.4 Million USD | 127.69% |
| 2012 Q4 | 41.85 Million USD | 16.87% |
| 2011 Q2 | -21.37 Million USD | -66.95% |
| 2011 FY | - USD | -765.22% |
| 2011 Q3 | -18.32 Million USD | 14.29% |
| 2011 Q4 | -15.9 Million USD | 13.19% |
| 2011 Q1 | -12.8 Million USD | -374.61% |
| 2010 Q3 | 136 Thousand USD | -92.11% |
| 2010 Q2 | 1.72 Million USD | 111.89% |
| 2010 Q1 | -14.49 Million USD | -361.54% |
| 2010 Q4 | 4.66 Million USD | 3328.68% |
| 2010 FY | - USD | -61.64% |
| 2009 Q3 | 2.11 Million USD | -78.56% |
| 2009 FY | - USD | 47.09% |
| 2009 Q1 | -5.82 Million USD | -39.05% |
| 2009 Q2 | 9.86 Million USD | 269.47% |
| 2009 Q4 | 5.54 Million USD | 162.08% |
| 2008 Q4 | -4.18 Million USD | 22.82% |
| 2008 FY | - USD | 74.15% |
| 2008 Q2 | -7.57 Million USD | -198.39% |
| 2008 Q1 | 7.7 Million USD | 217.28% |
| 2008 Q3 | -5.42 Million USD | 28.43% |
| 2007 Q3 | -9.27 Million USD | -11.01% |
| 2007 Q1 | -9.6 Million USD | -16.54% |
| 2007 FY | - USD | -16.69% |
| 2007 Q4 | -6.56 Million USD | 29.17% |
| 2007 Q2 | -8.35 Million USD | 13.06% |
| 2006 Q3 | -6.75 Million USD | 2.26% |
| 2006 Q2 | -6.9 Million USD | 23.21% |
| 2006 Q1 | -8.99 Million USD | -105.58% |
| 2006 FY | - USD | -99.07% |
| 2006 Q4 | -8.24 Million USD | -22.11% |
| 2005 Q1 | -5.06 Million USD | -14.55% |
| 2005 Q4 | -4.37 Million USD | -206.86% |
| 2005 Q3 | -1.42 Million USD | 69.38% |
| 2005 Q2 | -4.65 Million USD | 7.99% |
| 2005 FY | - USD | 32.98% |
| 2004 Q1 | -7.32 Million USD | -9.28% |
| 2004 Q3 | -5.12 Million USD | 29.16% |
| 2004 Q4 | -4.41 Million USD | 13.75% |
| 2004 Q2 | -7.23 Million USD | 1.27% |
| 2004 FY | - USD | -9.46% |
| 2003 Q3 | -4.32 Million USD | -34.94% |
| 2003 Q2 | -3.2 Million USD | -1.92% |
| 2003 Q1 | -3.14 Million USD | 16.56% |
| 2003 FY | - USD | -8.32% |
| 2003 Q4 | -6.7 Million USD | -54.79% |
| 2002 Q4 | -3.77 Million USD | -16.74% |
| 2002 Q1 | -7.62 Million USD | -69.73% |
| 2002 Q2 | -7.58 Million USD | 35.85% |
| 2002 Q3 | -5.02 Million USD | 33.97% |
| 2002 FY | - USD | -740.68% |
| 2001 Q3 | -3.22 Million USD | 352.92% |
| 2001 Q1 | -3.44 Million USD | -5.36% |
| 2001 Q2 | -3.67 Million USD | -6.59% |
| 2001 Q4 | -4.49 Million USD | -148.36% |
| 2001 FY | - USD | 76.36% |
| 2000 FY | - USD | -24.36% |
| 2000 Q2 | -2.87 Million USD | -146.58% |
| 2000 Q1 | -1.16 Million USD | 49.22% |
| 2000 Q3 | -2.5 Million USD | 13.03% |
| 2000 Q4 | -3.27 Million USD | -30.64% |
| 1999 Q4 | -2.3 Million USD | -15.0% |
| 1999 FY | - USD | -168.7% |
| 1999 Q1 | -1.5 Million USD | 42.31% |
| 1999 Q3 | -2.09 Million USD | -5.26% |
| 1999 Q2 | -1.9 Million USD | -26.67% |
| 1998 Q2 | -1.7 Million USD | -6.25% |
| 1998 Q3 | -1.7 Million USD | 1141.18% |
| 1998 FY | - USD | 402.63% |
| 1998 Q4 | -2.6 Million USD | -114.69% |
| 1998 Q1 | -1.4 Million USD | -77.78% |
| 1997 Q1 | -500 Thousand USD | -40.0% |
| 1997 Q3 | -1.1 Million USD | 0.0% |
| 1997 FY | - USD | -100.0% |
| 1997 Q4 | -800 Thousand USD | 18.18% |
| 1997 Q2 | -1 Million USD | -57.14% |
| 1996 Q3 | -440 Thousand USD | 0.0% |
| 1996 FY | - USD | 9.52% |
| 1996 Q1 | 50 Thousand USD | 0.0% |
| 1996 Q4 | -500 Thousand USD | -13.64% |
| 1996 Q2 | -440 Thousand USD | -980.0% |
| 1995 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -6.86 Million USD | -6294.817% |
| Jaguar Health, Inc. | -33.13 Million USD | -1225.635% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -188.609% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -673.859% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -70.071% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 531.74% |
| ContextLogic Inc. | -324 Million USD | -35.554% |
| MiMedx Group, Inc. | 40.51 Million USD | 1183.98% |
| MEI Pharma, Inc. | 26.38 Million USD | 1764.882% |
| AlloVir, Inc. | -190.14 Million USD | -130.978% |
| Novavax, Inc. | -487.39 Million USD | 9.888% |
| Aptorum Group Limited | -9.59 Million USD | -4475.436% |
| Ardelyx, Inc. | -55.35 Million USD | -693.431% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -150.009% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -15861.593% |
| Vaxcyte, Inc. | -464.88 Million USD | 5.526% |
| Precigen, Inc. | -89.22 Million USD | -392.229% |
| Pharming Group N.V. | 9.87 Million USD | 4546.654% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -176.139% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1829.514% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2486.397% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -88.095% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -2343.582% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1721.491% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1721.491% |
| Bicycle Therapeutics plc | -183.4 Million USD | -139.474% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -402.357% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1416.404% |
| Acelyrin, Inc. | -381.52 Million USD | -15.116% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 83123.819% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1215.509% |
| Senti Biosciences, Inc. | -61.33 Million USD | -616.049% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -291.078% |
| AbCellera Biologics Inc. | -192.15 Million USD | -128.56% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1321.162% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -165.502% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -136721.184% |
| Chimerix, Inc. | -92.97 Million USD | -372.386% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1253.329% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2078.66% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -888.363% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -837.211% |
| Elevation Oncology, Inc. | -41.46 Million USD | -959.146% |
| Alkermes plc | 495.04 Million USD | 188.718% |
| Fortress Biotech, Inc. | -133.64 Million USD | -228.634% |
| Fortress Biotech, Inc. | -133.64 Million USD | -228.634% |
| Agenus Inc. | -145.92 Million USD | -200.976% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -467.855% |
| Dyadic International, Inc. | -8.22 Million USD | -5236.694% |
| ImmuCell Corporation | -2.5 Million USD | -17439.237% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -150826.46% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -236.753% |
| Lantern Pharma Inc. | -15.78 Million USD | -2682.065% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2621.899% |
| Incyte Corporation | 919.42 Million USD | 147.768% |
| IO Biotech, Inc. | -91.22 Million USD | -381.427% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -518.377% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2105.641% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -665.471% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -179.396% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -5131.015% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -487.044% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -15.587% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | 18.657% |
| NextCure, Inc. | -59.03 Million USD | -643.908% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -4306.059% |
| Onconetix, Inc. | -36.7 Million USD | -1096.5% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 19750.828% |
| Opthea Limited | -200.01 Million USD | -119.577% |
| PDS Biotechnology Corporation | -40.08 Million USD | -995.663% |
| PureTech Health plc | -11.62 Million USD | -3677.38% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -459.535% |
| Seer, Inc. | -97.88 Million USD | -348.686% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -3408512.724% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1804.745% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -7080.458% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1401.114% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -647.059% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1750.415% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -259.693% |
| ChromaDex Corporation | -3.89 Million USD | -11178.788% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -6279.954% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -290.278% |
| CRISPR Therapeutics AG | -202.7 Million USD | -116.672% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1270.688% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -155.007% |
| Innoviva, Inc. | 248.96 Million USD | 276.412% |
| Summit Therapeutics Inc. | 1 Million USD | 43975.724% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -606.137% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -571.913% |
| ESSA Pharma Inc. | -26.45 Million USD | -1560.143% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1022.632% |
| GT Biopharma, Inc. | 5.97 Million USD | 7445.643% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -112.487% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 605.916% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -757.486% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -4342.199% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -85.611% |
| Aptose Biosciences Inc. | -52.26 Million USD | -740.277% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -307.632% |
| Soligenix, Inc. | -7.85 Million USD | -5492.823% |
| Century Therapeutics, Inc. | -121.2 Million USD | -262.349% |
| Kura Oncology, Inc. | -164.95 Million USD | -166.252% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -448.323% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -4254.511% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -45757.588% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -10092.527% |
| Autolus Therapeutics plc | -156.77 Million USD | -180.153% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -418.795% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -536.507% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2103.251% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -132.044% |
| GRI Bio, Inc. | -10.89 Million USD | -3930.061% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -9625.946% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -258.51% |
| IGM Biosciences, Inc. | -253.35 Million USD | -73.35% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -323.15% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1051.741% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2764.775% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2689.743% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -672.62% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -310.069% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -65.113% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -126.461% |
| Verastem, Inc. | -83.16 Million USD | -428.096% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -768.457% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -177.572% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -284.959% |
| Histogen Inc. | -10.5 Million USD | -4081.624% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2975.665% |
| Surrozen, Inc. | -41.13 Million USD | -967.798% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2866.338% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 13695017.368% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -648.036% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -756.233% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1939.073% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -5167.399% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -164.47% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -791.615% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1717.413% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2817.269% |
| Apollomics, Inc. | -171.74 Million USD | -155.723% |
| Amarin Corporation plc | -50.9 Million USD | -762.835% |
| Mesoblast Limited | -61.33 Million USD | -616.108% |
| Turnstone Biologics Corp. | -56.23 Million USD | -681.015% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -206.699% |
| Synaptogenix, Inc. | -8.3 Million USD | -5186.736% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2763.264% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -596.617% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -9066.213% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 102467.384% |
| Exelixis, Inc. | 196.6 Million USD | 323.393% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1047.865% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -210.586% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 11.311% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3623.371% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 177756.786% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1388.497% |
| Gritstone bio, Inc. | -126.86 Million USD | -246.197% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -575.842% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -10880.048% |
| Avid Bioservices, Inc. | -11.48 Million USD | -3725.416% |
| Insmed Incorporated | -654.73 Million USD | 32.92% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -19422.26% |
| MediWound Ltd. | -4.89 Million USD | -8876.007% |
| OmniAb, Inc. | -49.73 Million USD | -783.143% |
| Alector, Inc. | -142.89 Million USD | -207.362% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -414.076% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -742.211% |
| Zai Lab Limited | -366.57 Million USD | -19.811% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -51.115% |
| Aura Biosciences, Inc. | -83.69 Million USD | -424.751% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -94.982% |
| Immunic, Inc. | -99.11 Million USD | -343.131% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -233.558% |
| Veracyte, Inc. | -49.4 Million USD | -788.899% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -6117.445% |
| FibroGen, Inc. | -261.4 Million USD | -68.014% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3842.16% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -6173.038% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2246.525% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 130.301% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1627.622% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1201.018% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1782.743% |
| Galecto, Inc. | -37.51 Million USD | -1070.596% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1047.775% |
| Fortrea Holdings Inc. | 167.3 Million USD | 362.52% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -227.075% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1451.326% |
| XBiotech Inc. | -35.76 Million USD | -1127.971% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -575.842% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -573.097% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -320.464% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1610.798% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -974.696% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 14.959% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -683.985% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -783464.968% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -277.527% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1881.077% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -86.841% |
| NexImmune, Inc. | -28.16 Million USD | -1459.229% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -7848.46% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -3624.439% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 109.437% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1629.663% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3649.598% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -248.995% |
| Ainos, Inc. | -8.77 Million USD | -4906.168% |
| Pluri Inc. | -20.22 Million USD | -2071.55% |
| Prothena Corporation plc | -190.1 Million USD | -131.024% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -242.592% |
| Celularity Inc. | -183.94 Million USD | -138.764% |
| Rallybio Corporation | -72.37 Million USD | -506.851% |
| Cue Biopharma, Inc. | -46.05 Million USD | -853.696% |
| MeiraGTx Holdings plc | -57.05 Million USD | -669.817% |
| Omeros Corporation | -163.61 Million USD | -168.441% |
| Humacyte, Inc. | -96.45 Million USD | -355.324% |
| Immunocore Holdings plc | -59.64 Million USD | -636.301% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2167.169% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1702.569% |
| Blueprint Medicines Corporation | -474.61 Million USD | 7.462% |
| CalciMedica, Inc. | -34.18 Million USD | -1184.612% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -499.716% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -249.965% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -160.726% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -74.015% |
| Pulmatrix, Inc. | -12.64 Million USD | -3373.003% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1232.27% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -396.452% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 13.256% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -333.924% |
| Cytokinetics, Incorporated | -456.68 Million USD | 3.829% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1216.022% |
| Nutriband Inc. | -5.12 Million USD | -8475.071% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -914.966% |
| Vor Biopharma Inc. | -114.37 Million USD | -284.01% |
| Roivant Sciences Ltd. | -996.51 Million USD | 55.927% |
| Evogene Ltd. | -23.2 Million USD | -1792.76% |
| ProKidney Corp. | -147.66 Million USD | -197.419% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -580.555% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -286676.93% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 22.331% |
| CorMedix Inc. | -48.88 Million USD | -798.39% |
| BioLineRx Ltd. | -57.06 Million USD | -669.696% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -292.988% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -217323.762% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1109.54% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -452.33% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -440.13% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -59.416% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1328.744% |
| MediciNova, Inc. | -9.87 Million USD | -4345.317% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -248.732% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -28601.85% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1546.855% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -95.206% |
| Biomea Fusion, Inc. | -124.62 Million USD | -252.428% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -32.953% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1585.585% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -130.744% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -91.003% |
| Absci Corporation | -95.45 Million USD | -360.098% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1362.768% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -310.011% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -88.112% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1821.663% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -111.319% |
| Allakos Inc. | -189.91 Million USD | -131.259% |
| Imunon, Inc. | -19.87 Million USD | -2109.427% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -304.819% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 505.447% |
| BioAtla, Inc. | -122.24 Million USD | -259.287% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3623.371% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -2686.6% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -46.256% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -959.657% |
| XOMA Corporation | -39.36 Million USD | -1015.787% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -342.497% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -273.307% |
| aTyr Pharma, Inc. | -52.17 Million USD | -741.726% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -424.006% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -195.494% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -87.239% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -3116.846% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -5361.075% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2513.951% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 232840.877% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 197.179% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6774.656% |
| UroGen Pharma Ltd. | -63.83 Million USD | -588.061% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -546.685% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5947.023% |
| Orgenesis Inc. | -60.71 Million USD | -623.337% |
| Entera Bio Ltd. | -8.8 Million USD | -4888.596% |
| GH Research PLC | -41.15 Million USD | -967.227% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1621.055% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -434.087% |
| Xencor, Inc. | -125.87 Million USD | -248.917% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -30687.392% |
| Replimune Group, Inc. | -230.19 Million USD | -90.791% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2078.809% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -3913.855% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -6774.656% |
| Portage Biotech Inc. | -18.19 Million USD | -2313.297% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -28601.85% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -319.946% |
| OncoCyte Corporation | -23.12 Million USD | -1799.39% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3786.566% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3733.483% |
| Purple Biotech Ltd. | -22.22 Million USD | -1876.135% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -6751.732% |
| scPharmaceuticals Inc. | -46.06 Million USD | -853.509% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -2366.052% |
| HilleVax, Inc. | -132.46 Million USD | -231.554% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -4030.499% |
| Tharimmune, Inc. | -9.3 Million USD | -4621.223% |
| Genprex, Inc. | -31.06 Million USD | -1313.999% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -134.205% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1300.765% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -57386.387% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 291143.312% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2789177.442% |
| Savara Inc. | -59.13 Million USD | -642.726% |
| Curis, Inc. | -45.13 Million USD | -872.986% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1330.535% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2791.131% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -6029.742% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1542.837% |
| BeiGene, Ltd. | -1.12 Billion USD | 60.947% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -2594.256% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -2.001% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -386.159% |
| Erasca, Inc. | -121.31 Million USD | -262.044% |
| bluebird bio, Inc. | -167.16 Million USD | -162.738% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -9662.61% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 241.546% |
| DBV Technologies S.A. | -85.98 Million USD | -410.8% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -9662.61% |
| Moderna, Inc. | -3.28 Billion USD | 86.622% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -930.759% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -7676.133% |
| Molecular Templates, Inc. | 1.43 Million USD | 30813.007% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -633.803% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -34.621% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -220.373% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -827.239% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -215.891% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -113.347% |
| MacroGenics, Inc. | 2.01 Million USD | 21874.715% |
| RenovoRx, Inc. | -11.39 Million USD | -3755.979% |
| Adicet Bio, Inc. | -136.53 Million USD | -221.673% |
| Prime Medicine, Inc. | -193.75 Million USD | -126.671% |
| Aditxt, Inc. | -25.45 Million USD | -1625.181% |
| Adagene Inc. | -14.95 Million USD | -2837.612% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5908.073% |
| Quantum-Si incorporated | -91.8 Million USD | -378.406% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 161.649% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 447.314% |
| SciSparc Ltd. | -5.28 Million USD | -8214.956% |
| Vericel Corporation | 2.86 Million USD | 15435.056% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -461201.571% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1924.744% |
| Generation Bio Co. | -133.3 Million USD | -229.479% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -428.961% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -410.556% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -93.109% |
| Invivyd, Inc. | -196.61 Million USD | -123.379% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -17.384% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -4635.37% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1717.427% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -4170.258% |
| 2seventy bio, Inc. | -206.41 Million USD | -112.77% |
| ADMA Biologics, Inc. | 5.12 Million USD | 8678.047% |
| Clene Inc. | -43.24 Million USD | -915.693% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1808.803% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -805.988% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1546.855% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -46.611% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1095.763% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1963.132% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 9044.464% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1252.121% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -177.263% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 35.819% |
| Evaxion Biotech A/S | -21.4 Million USD | -1952.03% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -561.29% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -101.772% |
| Trevena, Inc. | -35.28 Million USD | -1144.604% |
| Surrozen, Inc. | -41.13 Million USD | -967.798% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -451.809% |
| Cingulate Inc. | -22.95 Million USD | -1813.539% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -5786.557% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1078.006% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -5238.879% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -329.464% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -547.524% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -652.409% |
| Clearmind Medicine Inc. | -8.71 Million USD | -4942.05% |
| Kronos Bio, Inc. | -121.83 Million USD | -260.499% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -490.778% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -17889.411% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -335.594% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1228.025% |
| ImmunityBio, Inc. | -436.18 Million USD | -0.691% |
| Korro Bio, Inc. | -80.9 Million USD | -442.861% |
| Kineta, Inc. | -15.71 Million USD | -2694.934% |
| BioVie Inc. | -31.95 Million USD | -1274.626% |
| Codexis, Inc. | -49.28 Million USD | -791.171% |
| Celularity Inc. | -183.94 Million USD | -138.764% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -98.274% |
| Celcuity Inc. | -58.3 Million USD | -653.209% |
| Virax Biolabs Group Limited | -6.6 Million USD | -6545.278% |
| Cibus, Inc. | -314.58 Million USD | -39.611% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1201.977% |
| IN8bio, Inc. | -28.5 Million USD | -1440.822% |
| Kodiak Sciences Inc. | -259.02 Million USD | -69.559% |
| Annexon, Inc. | -141.57 Million USD | -210.221% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -290.053% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -584.149% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1471.082% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -90.946% |
| Eyenovia, Inc. | -24.1 Million USD | -1721.934% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1080.698% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -135454.321% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -495.084% |
| Arcellx, Inc. | -64.14 Million USD | -584.692% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -875.688% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -255.693% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1322.175% |
| Moolec Science SA | -52.07 Million USD | -743.383% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -751.056% |
| Geron Corporation | -174.78 Million USD | -151.282% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -986.662% |
| Royalty Pharma plc | 1.88 Billion USD | 123.271% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -267.242% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4610.253% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2017.551% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -164.448% |
| Humacyte, Inc. | -96.45 Million USD | -355.324% |
| Structure Therapeutics Inc. | -102.45 Million USD | -328.655% |
| 89bio, Inc. | -134.46 Million USD | -226.63% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -456.825% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 10938.993% |
| Genelux Corporation | -24.16 Million USD | -1717.488% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1199.396% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -168.681% |
| Notable Labs, Ltd. | -14.4 Million USD | -2949.972% |
| Liquidia Corporation | -70.05 Million USD | -526.966% |
| Mustang Bio, Inc. | -48.06 Million USD | -813.792% |
| Immunovant, Inc. | -269.97 Million USD | -62.678% |
| Quantum-Si incorporated | -91.8 Million USD | -378.406% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -518.708% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2174.684% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -330.534% |
| Acasti Pharma Inc. | -11.3 Million USD | -3786.346% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1873.627% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2764.775% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -108.631% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -10184.794% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2665.718% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1426.258% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1086.055% |
| PepGen Inc. | -83.58 Million USD | -425.467% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1388.598% |
| United Therapeutics Corporation | 1.38 Billion USD | 131.67% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1818.138% |
| Solid Biosciences Inc. | -93.43 Million USD | -370.06% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -9104.114% |
| Immuneering Corporation | -58.06 Million USD | -656.441% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 13695017.368% |
| Silo Pharma, Inc. | -3.62 Million USD | -12011.696% |
| Belite Bio, Inc | -31.52 Million USD | -1292.991% |
| XOMA Corporation | -39.36 Million USD | -1015.787% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -551.172% |
| Bionomics Limited | -9.83 Million USD | -4364.737% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -422.946% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1169.133% |
| uniQure N.V. | -253.1 Million USD | -73.527% |
| Cassava Sciences, Inc. | -95.68 Million USD | -358.992% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5908.073% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -239.137% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1252.329% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -5355.53% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1456.384% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -135454.321% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3842.16% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2662.065% |
| Altimmune, Inc. | -87.93 Million USD | -399.455% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -376.977% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1169.133% |
| Compugen Ltd. | -12.51 Million USD | -3409.076% |
| Peak Bio, Inc. | -1356.23 USD | -32383492.753% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -803.733% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1852.85% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -81.259% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1438.717% |
| Zura Bio Limited | -60.56 Million USD | -625.189% |
| PolyPid Ltd. | -20.26 Million USD | -2067.478% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2713.015% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1438.717% |
| Instil Bio, Inc. | -146.12 Million USD | -200.568% |
| argenx SE | -216.02 Million USD | -103.31% |
| Immunome, Inc. | -28.27 Million USD | -1453.521% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -806.063% |
| Verona Pharma plc | -52.46 Million USD | -737.081% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -363.424% |
| Shattuck Labs, Inc. | -87.61 Million USD | -401.279% |
| CervoMed Inc. | -2.17 Million USD | -20121.983% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -259.278% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -3360.143% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -811.687% |
| Moolec Science SA | -52.07 Million USD | -743.383% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2462.406% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -236.83% |
| AnaptysBio, Inc. | -143.16 Million USD | -206.778% |
| Design Therapeutics, Inc. | -66.32 Million USD | -562.188% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -442.304% |
| NeurAxis, Inc. | -6.66 Million USD | -6490.087% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1063.433% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1100.973% |
| Achilles Therapeutics plc | -70.44 Million USD | -523.486% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -363.424% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1884.257% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 7634.352% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -17889.411% |
| Nutriband Inc. | -5.12 Million USD | -8475.071% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -300.186% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -692.315% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -768.835% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -572.819% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -711.673% |
| Palisade Bio, Inc. | -12.28 Million USD | -3476.223% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -867.904% |
| Beam Therapeutics Inc. | -156.47 Million USD | -180.685% |
| Neurogene Inc. | -52.28 Million USD | -739.988% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -221.779% |
| AEON Biopharma, Inc. | -48.36 Million USD | -808.162% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -372.162% |
| Sesen Bio, Inc. | -50.84 Million USD | -763.879% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -436.049% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -3456.236% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -2.752% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -317.499% |
| Athira Pharma, Inc. | -116.7 Million USD | -276.337% |
| Vaccinex, Inc. | -19.74 Million USD | -2124.002% |
| HCW Biologics Inc. | -23.57 Million USD | -1762.89% |
| XOMA Corporation | -39.36 Million USD | -1015.787% |
| Nektar Therapeutics | -243.1 Million USD | -80.66% |
| Arvinas, Inc. | -394.8 Million USD | -11.245% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 232840.877% |
| Merus N.V. | -149.2 Million USD | -194.353% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -369.779% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1304.978% |
| Rezolute, Inc. | -68.42 Million USD | -541.884% |
| Clene Inc. | -43.24 Million USD | -915.693% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2747.819% |
| BeyondSpring Inc. | -21.54 Million USD | -1938.979% |
| Synlogic, Inc. | -55.16 Million USD | -696.207% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -3534.826% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -4027.006% |
| Peak Bio, Inc. | -1356.23 USD | -32383492.753% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1252.829% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2553.061% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -270.871% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -28.666% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -9434.408% |
| MannKind Corporation | 15.12 Million USD | 3003.007% |
| Ikena Oncology, Inc. | -74.39 Million USD | -490.341% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -3387.62% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2260.653% |
| Gossamer Bio, Inc. | -172.15 Million USD | -155.121% |
| CohBar, Inc. | -12.06 Million USD | -3540.02% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1621.73% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1362.768% |
| Legend Biotech Corporation | -477.87 Million USD | 8.094% |
| Mural Oncology plc | -192.72 Million USD | -127.893% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -285.077% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2620.277% |
| Disc Medicine, Inc. | -91.02 Million USD | -382.5% |
| Champions Oncology, Inc. | -5.05 Million USD | -8590.067% |
| REGENXBIO Inc. | -239.46 Million USD | -83.408% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3997.671% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -687.711% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1032.875% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -289.337% |
| Vaxart, Inc. | -74.72 Million USD | -487.765% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1147.422% |
| Cellectis S.A. | -98.09 Million USD | -347.725% |
| Longeveron Inc. | -20.06 Million USD | -2089.412% |
| Repare Therapeutics Inc. | -114.27 Million USD | -284.339% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -487.066% |
| Revolution Medicines, Inc. | -430.58 Million USD | -2.001% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -6883.559% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1326.47% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -488.814% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 9057.699% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -3905.435% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 109.537% |
| Denali Therapeutics Inc. | -179.97 Million USD | -144.034% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -461201.571% |
| Veru Inc. | -89.97 Million USD | -388.128% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1534.035% |
| Cingulate Inc. | -22.95 Million USD | -1813.539% |
| Passage Bio, Inc. | -98.34 Million USD | -346.605% |
| Context Therapeutics Inc. | -25.06 Million USD | -1652.538% |
| Exicure, Inc. | -15.53 Million USD | -2726.411% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -113.136% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1087.787% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -7265.852% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -160.706% |
| Nuvalent, Inc. | -149.49 Million USD | -193.792% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -5300.561% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -411.323% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1355.352% |
| OmniAb, Inc. | -49.73 Million USD | -783.143% |
| Anew Medical, Inc. | -1.3 Million USD | -33662.492% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -3452.216% |
| Lipocine Inc. | -16.32 Million USD | -2590.712% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -558.761% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -491.088% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1051.741% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1025.739% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1879.876% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 19.424% |
| Ocugen, Inc. | -64.82 Million USD | -577.489% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -374.447% |
| Q32 Bio Inc. | -86.5 Million USD | -407.729% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2494.648% |
| Alumis Inc. Common Stock | -156.89 Million USD | -179.939% |
| Equillium, Inc. | -12.13 Million USD | -3518.356% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -651.122% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -5457.087% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2228.597% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -840.624% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -312.992% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -2355.448% |
| Dominari Holdings Inc. | -22.44 Million USD | -1857.201% |
| Edesa Biotech, Inc. | -8.19 Million USD | -5262.496% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1628.302% |
| Bio-Techne Corporation | 326.66 Million USD | 234.449% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -14.117% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 302.966% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -234.988% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1073.348% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -190.664% |
| Nkarta, Inc. | -120.48 Million USD | -264.535% |
| BioCardia, Inc. | -11.56 Million USD | -3699.273% |
| Iterum Therapeutics plc | -34.58 Million USD | -1170.087% |